TGA
We are reviewing the safety information supporting notifications of the highest-risk implantable and cardiac invasive medical devices used in first-in-human clinical trials.
This was part of our commitment in the 2019 Action Plan for Medical Devices, and the changes have been made in response to feedback from the consultation on proposed regulatory changes for clinical trials of medical devices.
/Public Release. View in full here.
